![](/images/graphics-bg.png)
The value of serum FGF-23 as a cardiovascular marker in HD patients
المؤلفون المشاركون
Abd al-Rahman, Muhammad
al-Shahawy, Yasir
Aziz, Ahmad
Sani, Dawlat
al-Sawi, Abd al-Basit
Ahmad, Hayam
Arif, Hayam
المصدر
Saudi Journal of Kidney Diseases and Transplantation
العدد
المجلد 25، العدد 1 (28 فبراير/شباط 2014)، ص ص. 44-52، 9ص.
الناشر
تاريخ النشر
2014-02-28
دولة النشر
السعودية
عدد الصفحات
9
التخصصات الرئيسية
الموضوعات
الملخص EN
-Fibroblast growth factor 23 (FGF-23) is a recently discovered regulator of phosphate and mineral metabolism and has been associated with both progression of CKD and mortality in dialysis patients.
To evaluate the association between serum FGF-23 levels and echocardiographic measurements in long-term HD (HD) patients without cardiac symptoms, we studied 90 consecutive patients treated in a single HD center (51 males, 39 females; mean age 41.5 ± 14.2 years, mean HD duration 71.2 ± 14.2 months).
Comprehensive echocardiography was performed after HD and blood samples were obtained before HD.
The serum FGF-23 level in dialysis patients was 95.7 ± 88.4 pg/mL.
In univariate analysis, serum calcium levels (r = 0.33, P <0.05), serum creatinine (r = 0.34, P <0.05), serum albumin (r = 0.35, P <0.05) and left ventricular mass index (LVMI) (r = 0.33, P <0.001) were correlated weakly with the FGF-23 levels.
Neither s.
phosphorus nor calcium x phosphorus product correlated with FGF-23.
In univariate regression analysis, only LVMI [β = 0.42, P <0.05, confidence interval (CI) 0.3–4.3], serum calcium (β = 0.87, P <0.001, CI 0.8–7.3), serum albumin (β = 0.87, P < 0.001, CI 0.8–7.3) and serum creatinine (β = 0.67, P <0.05, CI 0.5–6.5) significantly correlated with FGF-23.
FGF-23 was identified as a factor that is weakly associated with LVMI.
Thus, FGF-23 alone may not be a parameter that can be used for evaluation of the cardiac status in HD patients.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Sani, Dawlat& al-Sawi, Abd al-Basit& Aziz, Ahmad& al-Shahawy, Yasir& Ahmad, Hayam& Arif, Hayam…[et al.]. 2014. The value of serum FGF-23 as a cardiovascular marker in HD patients. Saudi Journal of Kidney Diseases and Transplantation،Vol. 25, no. 1, pp.44-52.
https://search.emarefa.net/detail/BIM-356556
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Sani, Dawlat…[et al.]. The value of serum FGF-23 as a cardiovascular marker in HD patients. Saudi Journal of Kidney Diseases and Transplantation Vol. 25, no. 1 (Jan. / Feb. 2014), pp.44-52.
https://search.emarefa.net/detail/BIM-356556
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Sani, Dawlat& al-Sawi, Abd al-Basit& Aziz, Ahmad& al-Shahawy, Yasir& Ahmad, Hayam& Arif, Hayam…[et al.]. The value of serum FGF-23 as a cardiovascular marker in HD patients. Saudi Journal of Kidney Diseases and Transplantation. 2014. Vol. 25, no. 1, pp.44-52.
https://search.emarefa.net/detail/BIM-356556
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 50-52
رقم السجل
BIM-356556
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)